| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2014 | US20140364375 Combination Therapy with Peptide Epoxyketones |
| 12/11/2014 | US20140364373 Novel enteric combination therapy |
| 12/11/2014 | US20140364368 Stimulus responsive nanocomplexes and methods of use thereof |
| 12/11/2014 | US20140364367 Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a katp channel opener |
| 12/11/2014 | US20140364364 Compounds for use in treatment of mucositis |
| 12/11/2014 | US20140363673 Therapeutic agent for inflammatory bowel disease |
| 12/11/2014 | US20140363529 Compounds influencing fatty acid uptake and metabolism and methods of isolating from cocoa products |
| 12/11/2014 | US20140363528 Composition for preventing or ameliorating snoring |
| 12/11/2014 | US20140363524 Dialysis precursor composition |
| 12/11/2014 | US20140363523 Deuterated alpha-lipoic acid |
| 12/11/2014 | US20140363522 Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins |
| 12/11/2014 | US20140363516 Multiple unit pellet tablet formulation comprising an opioid |
| 12/11/2014 | US20140363514 Core-shell particle formulation for delivering multiple therapeutic agents |
| 12/11/2014 | US20140363512 Oral pharmaceutical composition |
| 12/11/2014 | US20140363511 Method of treating middle ear infections |
| 12/11/2014 | US20140363510 Pharmaceutical composition including pimobendan |
| 12/11/2014 | US20140363509 Compositions for the treatment of mucous membrane diseases |
| 12/11/2014 | US20140363508 Pharmaceutical formulations of flurbiprofen and glucosamin |
| 12/11/2014 | US20140363506 Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| 12/11/2014 | US20140363505 New combination |
| 12/11/2014 | US20140363504 Absorbable encapsulated calcium in hypromellose capsule |
| 12/11/2014 | US20140363503 Chewable soft capsules |
| 12/11/2014 | US20140363502 Resveratrol-Containing Compositions and Methods of Use for Treatment of Macular Degeneration |
| 12/11/2014 | US20140363498 Hydrogel polymeric compositions and methods |
| 12/11/2014 | US20140363497 Nanocell Drug Delivery System |
| 12/11/2014 | US20140363493 LIPID NANOPARTICLES FOR TARGETED siRNA DELIVERY |
| 12/11/2014 | US20140363491 Novel liposome compositions |
| 12/11/2014 | US20140363490 Oligomer-contained nanoparticle complex release system |
| 12/11/2014 | US20140363488 Adhesive patch |
| 12/11/2014 | US20140363487 Transdermal delivery system comprising buprenorphine |
| 12/11/2014 | US20140363486 Methods for reducing or altering scar formation |
| 12/11/2014 | US20140363482 Bioerodible Sustained Release Drug Delivery Systems |
| 12/11/2014 | US20140363479 Compositions and methods for treating extracellular parasitic infections |
| 12/11/2014 | US20140363455 Dll3 modulators and methods of use |
| 12/11/2014 | US20140363454 Antibody-Drug Conjugates, Compositions and Methods of Use |
| 12/11/2014 | US20140363451 Anti-FOLR1 Immunoconjugate Dosing Regimens |
| 12/11/2014 | US20140363443 Tricyclic carbamate jak inhibitors |
| 12/11/2014 | US20140363441 Compositions and methods for the therapy and diagnosis of influenza |
| 12/11/2014 | US20140363437 Combination therapy for a stable and long term engraftment |
| 12/11/2014 | US20140363427 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| 12/11/2014 | US20140363420 Method and composition for topical pain relief |
| 12/11/2014 | US20140363418 Method of producing collagen from hydrolyzed egg membrane |
| 12/11/2014 | US20140363413 Formulation and method for the prevention and treatment of bone metastases or other bone diseases |
| 12/11/2014 | US20140363402 Composition and method for muscle repair and regeneration |
| 12/11/2014 | US20140363396 Once daily treatment of hepatitis c with ribavirin and taribavirin |
| 12/11/2014 | US20140363395 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 12/11/2014 | US20140363394 Formulation having mobilizing activity |
| 12/11/2014 | US20140363393 Method and Composition for In Situ Formation and/or Expansion of a Polymer-Based Hemostatic Agent to Control Bleeding |
| 12/11/2014 | US20140363391 System and method for administering poloxamers and anesthetics while performing cpr and minimizing reperfusion injury |
| 12/11/2014 | US20140363388 Series of skin whitening (lightening) compounds |
| 12/11/2014 | US20140363384 Combination therapy for copd |
| 12/11/2014 | US20140363383 Aerosol formulation for copd |
| 12/11/2014 | US20140363380 Mex3c regulation and target to control obesity and diabetes |
| 12/11/2014 | US20140363379 Nutritional approach to the use of ergothioneine and vitamin d2 for hair, nail and skin growth |
| 12/11/2014 | US20140363377 Procaspase 8-mediated disease targeting |
| 12/11/2014 | US20140361045 Preparation of therapeutic foam |
| 12/10/2014 | CN203989092U 包埋结构 Embedded structure |
| 12/10/2014 | CN1767831B 包含甲基纳曲酮的药物配方 Containing methylnaltrexone pharmaceutical formulations |
| 12/10/2014 | CN1642540B 作为局部杀微生物药和避孕药的苏拉明及其衍生物 Topical microbicides as drugs and contraceptives suramin and its derivatives |
| 12/10/2014 | CN104204082A 高分子化氮氧化合物与无机颗粒的有机-无机杂合复合物 Organic macromolecular nitroxide compound and inorganic particles - inorganic hybrid composite |
| 12/10/2014 | CN104204057A 噻苯咪唑和含碘杀真菌剂的稳定组合物 Thiabendazole and iodine fungicides stabilizing composition |
| 12/10/2014 | CN104203969A 1-(2-脱氧-2-氟-4-硫代-β-D-阿拉伯呋喃糖基)胞嘧啶的盐 1- (2-deoxy-2-fluoro-4-thio -β-D- arabinofuranosyl) cytosine salt |
| 12/10/2014 | CN104203965A 锗与氨基酸和羧酸的配合物及其制备方法 Germanium complexes with amino acids and carboxylic acid and its preparation method |
| 12/10/2014 | CN104203959A 雷帕霉素40-o-环状烃酯、组合物和方法 Rapamycin 40-o- cyclic hydrocarbon esters, compositions and methods |
| 12/10/2014 | CN104203958A 二环杂环衍生物、其制备及治疗用途 Bicyclic heterocyclic derivatives, their preparation and therapeutic use |
| 12/10/2014 | CN104203956A 用于治疗癌症的功能化的噻吩并吲哚衍生物 For the treatment of cancer functionalized thieno indole derivative |
| 12/10/2014 | CN104203954A 三环磺酰胺化合物及其制备和使用方法 Tricyclic sulfonamide compounds and their preparation and use |
| 12/10/2014 | CN104203953A (s)-4-氨基-n-(1-(4-氯苯基)-3-羟丙基)-1-(7h-吡咯并[2,3-d]嘧啶-4-基)哌啶-4-甲酰胺的晶型 (S) -4- amino -n- (1- (4- chlorophenyl) -3-hydroxypropyl) -1- (7h- pyrrolo [2,3-d] pyrimidin-4-yl) piperidine 4-carboxamide in crystalline form |
| 12/10/2014 | CN104203952A 咪唑并吡咯烷酮化合物 Imidazole compounds and pyrrolidone |
| 12/10/2014 | CN104203951A 肝x受体调节剂 Liver x receptor modulators |
| 12/10/2014 | CN104203950A 肝x受体调节剂 Liver x receptor modulators |
| 12/10/2014 | CN104203949A 用于治疗丙型肝炎的化合物 Compounds for the treatment of hepatitis C |
| 12/10/2014 | CN104203948A 1H-吡咯并[2,3-b]吡啶衍生物及它们作为激酶抑制剂的用途 1H- pyrrolo [2,3-b] pyridine derivatives and their use as kinase inhibitors |
| 12/10/2014 | CN104203946A 免疫上有用的精氨酸盐 Useful arginine on immunity |
| 12/10/2014 | CN104203943A 取代的嘧啶化合物及其作为syk抑制剂的用途 Substituted pyrimidine compounds and their use as inhibitors of syk use |
| 12/10/2014 | CN104203942A 前列腺特异性膜抗原(psma)的同源多价抑制剂和异源多价抑制剂以及其用途 Prostate-specific membrane antigen (psma) homologous and heterologous multivalent inhibitor polyvalent inhibitors and their use |
| 12/10/2014 | CN104203940A 作为hcv抑制剂的杂双环衍生物 Heterobicyclic derivatives as inhibitors hcv |
| 12/10/2014 | CN104203939A 用作人呼吸道合胞病毒（rsv）抑制剂的二氨基嘧啶 As human respiratory syncytial virus (rsv) inhibitors diaminopyrimidine |
| 12/10/2014 | CN104203937A 作为btk活性的抑制剂的8-氟酞嗪-1(2h)-酮化合物 Btk activity as inhibitors of 8-fluoro-phthalazine -1 (2h) - keto compound |
| 12/10/2014 | CN104203936A 金属酶抑制剂化合物 Metal inhibitor compound |
| 12/10/2014 | CN104203935A 作为gpbar1调节剂的1，2-哒嗪，1，6-哒嗪或嘧啶-苯甲酰胺衍生物 As gpbar1 moderator 1,2 pyridazine, pyrimidine or pyridazine 1,6 - benzamide derivative |
| 12/10/2014 | CN104203928A 三嗪酮化合物及t型钙通道阻滞剂 Triazinone compounds and t-type calcium channel blockers |
| 12/10/2014 | CN104203926A 新类型的二氮杂*衍生物螯合剂及作为mri造影剂的其与顺磁性金属的配合物 * New types of diaza derivatives as chelating agents and its mri contrast agent complexes with paramagnetic metal |
| 12/10/2014 | CN104203924A 杂环化合物及其作为抗癌药的用途 Heterocyclic compounds and their use as anticancer agents |
| 12/10/2014 | CN104203922A 螺乙内酰脲化合物及其作为选择性雄激素受体调节剂的用途 Uses spiro hydantoin compounds and their use as selective androgen receptor modulators |
| 12/10/2014 | CN104203919A 可用作10a型磷酸二酯酶的抑制剂的杂环甲酰胺类 Can be used as a heterocyclic carboxamides 10a PDE inhibitors of phosphodiesterase type of |
| 12/10/2014 | CN104203918A 作为β2肾上腺素受体激动剂的5-(2-{[6-(2,2-二氟-2-苯乙氧基)己基]氨基}-1-(R)-羟乙基)-8-羟基喹啉-2(1H)-酮,半萘二磺酸盐的新的多晶型 As a β2 adrenergic receptor agonist 5- (2 - {[6- (2,2-difluoro-2-phenyl-ethoxy) hexyl] amino} -1- (R) - hydroxyethyl) -8 - hydroxyquinoline -2 (1H) - one, semi-naphthalene disulfonate new polymorph |
| 12/10/2014 | CN104203915A (3，4-二氯-苯基)-((s)-3-丙基-吡咯烷-3-基)-甲酮盐酸盐和制造方法 (3,4-dichloro - phenyl) - ((s) -3- propyl - pyrrolidin-3-yl) - methanone hydrochloride and methods of manufacture |
| 12/10/2014 | CN104203911A 芳氧基脲化合物和有害生物防除剂 Aryloxy urea compounds and a pest control agent |
| 12/10/2014 | CN104203906A 间位取代的联苯基外周限制性faah抑制剂 Meta-substituted limiting faah inhibitor outer periphery biphenyl |
| 12/10/2014 | CN104203901A 治疗炎症的组合物和方法 Therapeutic compositions and methods of inflammation |
| 12/10/2014 | CN104203288A Fads调节 Fads adjustment |
| 12/10/2014 | CN104203283A 纳米乳液组合物及其制备方法 Nano-emulsion composition and preparation method |
| 12/10/2014 | CN104203279A 脑癌的治疗 Brain cancer treatment |
| 12/10/2014 | CN104203267A 用于治疗流感和副流感患者的方法、化合物和组合物 Method for the treatment of patients with influenza and parainfluenza, compounds and compositions |
| 12/10/2014 | CN104203256A 用于引产的包含硫酸化的葡糖胺聚糖的联合治疗 Combination therapy for the induction of labor contain sulfated glycosaminoglycan |
| 12/10/2014 | CN104203255A 用于传递治疗剂的基于环糊精的聚合物 Cyclodextrin based polymers for delivery of therapeutic agents |
| 12/10/2014 | CN104203254A 含有地夸磷索的滴眼液 Containing phosphorus boast cord drops |
| 12/10/2014 | CN104203253A 取代的核苷、核苷酸及其类似物 Substituted nucleosides, nucleotides and analogues |
| 12/10/2014 | CN104203252A 注射剂用组合物 Injection composition |